Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on [gamma] [delta] T and NK Cells
Cells (Basel, Switzerland), 2020-08, Vol.9 (8), p.1 [Peer Reviewed Journal]COPYRIGHT 2020 MDPI AG ;ISSN: 2073-4409 ;EISSN: 2073-4409 ;DOI: 10.3390/cells9081757
Full text available